Broad-Spectrum Antibiotics for Severe Infection with Renal Impairment

First-Line Broad-Spectrum Regimens

The Infectious Diseases Society of America recommends piperacillin/tazobactam as the most versatile broad-spectrum option, covering gram-negatives, gram-positives (except MRSA), and anaerobes 1, 2
The American College of Clinical Pharmacy suggests that piperacillin/tazobactam is the preferred broad-spectrum antibiotic for patients with severe infection and impaired renal function, administered at full loading dose (4.5g) followed by adjusted maintenance dosing based on creatinine clearance, combined with vancomycin if MRSA is suspected 1, 2

The American Heart Association recommends vancomycin 30-60mg/kg/day in divided doses, targeting trough 15-20 mcg/mL for severe infections 5, 2
The Infectious Diseases Society of America suggests that linezolid 600mg every 12 hours has 100% oral bioavailability, with no renal adjustment needed 2, 3

The National Kidney Foundation recommends always administering full loading dose of selected antibiotic regardless of renal function, and adjusting only maintenance doses based on creatinine clearance 4

The American College of Clinical Pharmacy suggests daily renal function assessment in patients with shock, and therapeutic drug monitoring for vancomycin (target trough 15-20 mcg/mL) and aminoglycosides 4, 3

The Pediatric Infectious Diseases Society recommends piperacillin/tazobactam 200-300mg/kg/day of piperacillin component divided every 6-8 hours for pediatric patients 1
The Eastern Association for the Surgery of Trauma suggests immediate full-dose empiric therapy for penetrating abdominal/thoracic trauma, severe burns, open fractures 4